The Expected Outcome of the Trypanosoma cruzi Proteomic Map: A Review of Its Potential Biological Applications for Drug Target Discovery

作者: Rubem F. S. Menna-Barreto , Jonas Perales

DOI: 10.1007/978-94-007-7305-9_13

关键词:

摘要: Chagas disease is a neglected tropical illness endemic to Latin America, and its treatment remains unsatisfactory. This caused by the hemoflagellate protozoan Trypanosoma cruzi, which has complex life cycle involving three evolutive forms in both vertebrate invertebrate hosts. Targeting metabolic pathways parasite for rational drug design represents promising research field. area requires high performance techniques proteomics become powerful tool this context. Here, we review advances construction of proteomic maps different T. emphasizing their biological applications towards identification alternative candidates intervention.

参考文章(83)
Stoppani Ao, The chemotherapy of Chagas disease Medicina-buenos Aires. pp. 147- 165 ,(1999)
Jaime Paba, Jaime M. Santana, Antonio R. L. Teixeira, Wagner Fontes, Marcelo V. Sousa, Carlos A. O. Ricart, Proteomic analysis of the human pathogen Trypanosoma cruzi. Proteomics. ,vol. 4, pp. 1052- 1059 ,(2004) , 10.1002/PMIC.200300637
Fabíola B Holetz, Lysangela R Alves, Christian M Probst, Bruno Dallagiovanna, Fabricio K Marchini, Patricio Manque, Gregory Buck, Marco A Krieger, Alejandro Correa, Samuel Goldenberg, None, Protein and mRNA content of TcDHH1‐containing mRNPs in Trypanosoma cruzi FEBS Journal. ,vol. 277, pp. 3415- 3426 ,(2010) , 10.1111/J.1742-4658.2010.07747.X
Stefano Trapani, Jutta Linss, Samuel Goldenberg, Hannes Fischer, Aldo F. Craievich, Glaucius Oliva, Crystal structure of the dimeric phosphoenolpyruvate carboxykinase (PEPCK) from Trypanosoma cruzi at 2 A resolution. Journal of Molecular Biology. ,vol. 313, pp. 1059- 1072 ,(2001) , 10.1006/JMBI.2001.5093
Magaly Gonzales-Perdomo, Pedro Romero, Samuel Goldenberg, Cyclic AMP and adenylate cyclase activators stimulate Trypanosoma cruzi differentiation Experimental Parasitology. ,vol. 66, pp. 205- 212 ,(1988) , 10.1016/0014-4894(88)90092-6
Rubem F.S. Menna-Barreto, Daniela G. Beghini, André T.S. Ferreira, Antônio V. Pinto, Solange L. De Castro, Jonas Perales, A proteomic analysis of the mechanism of action of naphthoimidazoles in Trypanosoma cruzi epimastigotes in vitro Journal of Proteomics. ,vol. 73, pp. 2306- 2315 ,(2010) , 10.1016/J.JPROT.2010.07.002
Fernando Abad-Franch, Walter S. Santos, Christopher J. Schofield, Research needs for Chagas disease prevention Acta Tropica. ,vol. 115, pp. 44- 54 ,(2010) , 10.1016/J.ACTATROPICA.2010.03.002
J Antonio Marin-Neto, Anis Rassi Jr, Alvaro Avezum Jr, Antonio C Mattos, Anis Rassi, The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease Memorias Do Instituto Oswaldo Cruz. ,vol. 104, pp. 319- 324 ,(2009) , 10.1590/S0074-02762009000900042
Kelly Salomão, Eniuce M. de Souza, Andrea Henriques-Pons, Helene S. Barbosa, Solange L. de Castro, Brazilian Green Propolis: Effects In Vitro and In Vivo on Trypanosoma cruzi Evidence-based Complementary and Alternative Medicine. ,vol. 2011, pp. 185918- 185918 ,(2011) , 10.1093/ECAM/NEP014
Rubem F.S. Menna-Barreto, Kelly Salomão, Andréia P. Dantas, Ricardo M. Santa-Rita, Maurilio J. Soares, Helene S. Barbosa, Solange L. de Castro, Different cell death pathways induced by drugs in Trypanosoma cruzi: an ultrastructural study. Micron. ,vol. 40, pp. 157- 168 ,(2009) , 10.1016/J.MICRON.2008.08.003